Terapia Intensiva

A new article in OFID reviews COVID-19-associated fungal infections and addresses gaps in knowledge relating to the epidemiology, diagnosis and management of these infections: https://t.co/JIkkW70zHI #IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi @jobadd @DrPappasID pic.twitter.com/bPmFdKkjmb

— IDSA (@IDSAInfo) November 21, 2021

Estudo de coorte prospectivo mostrou um risco de 3,1% de tromboembolismo venoso recorrente em 90 dias em pacientes com embolia pulmonar subsegmentar tratada sem anticoagulação.

24 Nov, 2021 | 11:20h

Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation: A Multicenter Prospective Cohort Study – Annals of Internal Medicine (link para o resumo – $ para o texto completo)

Comentário no Twitter

First prospective study including patients with isolated SSPE managed without anticoagulation published in @AnnalsofIM. Rate of recurrent VTE is 3.1% . Nice collaboration between @INNOVTE1 and @canvector funded by @HeartandStroke https://t.co/GdcbM1fRp1 @OttMethodsCentr

— Marc Carrier (@MarcCarrier1) November 23, 2021

M-A | Colchicina não reduz a gravidade da COVID-19 nem evita o risco de morte.

23 Nov, 2021 | 15:53h

Comunicado de imprensa: Gout drug colchicine doesn’t lessen COVID-19 severity or stave off risk of death – BMJ

Estudo original: Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials – RMD Open

Conteúdos relacionados:

O paciente com COVID-19 na UTI cirúrgica.

23 Nov, 2021 | 15:49h

The COVID-19 Patient in the Surgical Intensive Care Unit – Surgical Clinics of North America

Diretriz IDSA sobre o tratamento de infecções por Gram-negativos resistentes a antibióticos.

23 Nov, 2021 | 15:46h

IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections – Infectious Diseases Society of America

Comentário no Twitter

IDSA has released NEW guidance on treating infections caused by three of the most common drug-resistant pathogens:

• AmpC-E
• CRAB
• S. maltophilia

Guidelines: https://t.co/gjxEZcxtmy
Press release: https://t.co/ulorKCmvQ4 #IDSAGuidelines #WAAW21 pic.twitter.com/Wy7uBaq2DN

— IDSA (@IDSAInfo) November 22, 2021

Suporte respiratório não invasivo no tratamento da pneumonia aguda por COVID-19: considerações para a prática clínica e prioridades para a pesquisa – “Dois estudos randomizados e controlados indicam superioridade da ventilação não invasiva sobre o oxigênio nasal de alto fluxo na redução da necessidade de intubação.”

22 Nov, 2021 | 09:38h

Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research – The Lancet Respiratory Medicine

Conteúdo relacionado: [Preprint] RCT: non-invasive respiratory strategies in acute respiratory failure in patients with COVID-19 – CPAP reduced the composite outcome of intubation or death within 30 days; high-flow nasal oxygenation was not associated with better outcomes.

Comentário no Twitter

NEW Personal View—Non-invasive respiratory support in the management of acute #COVID19 #pneumonia: considerations for clinical practice and priorities for research

From Prof Hugh Montgomery & colleagues https://t.co/LLEFz2VLFu pic.twitter.com/owgAjLX5Z6

— The Lancet Respiratory Medicine (@LancetRespirMed) November 10, 2021